Sofosbuvir Market
Sofosbuvir Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Sofosbuvir Market Size and Growth
Sofosbuvir market research reports indicate a significant growth trajectory, driven by rising hepatitis C prevalence and increasing antiviral drug demand. The global Sofosbuvir market size was valued at approximately $3 billion in 2022, with forecasts predicting continued expansion due to advancements in treatment protocols and enhanced patient access initiatives.
Companies Covered
(Covid 19 Impact Covered)
◍ Teva Pharmaceutical Industries Ltd
◍ DONG BANG FUTURE TECH & LIFE CO., LTD
◍ Beaukev Pharma International Pvt.Ltd
◍ DEAFARMA
◍ Tecoland
◍ Anhui HaiKang Pharmaceutical Co. Ltd
The Sofosbuvir market features companies like Teva, Dong Bang Future Tech, and Beaukev, which produce generics and formulations, enhancing accessibility. Others, like Anhui HaiKang and Shanghai Haoyuan, specialize in active pharmaceutical ingredients. Their efforts in manufacturing, distribution, and R&D foster market growth and competitive pricing.
Sales revenue figures:
◍ Shanghai Haoyuan Chemexpress Co., Ltd
- Teva Pharmaceutical: Approximately $16 billion (2022)
- Dong Bang Future Tech: Confidential
◍ Beijing Kawin Technology Share-holding Co
◍ Hangzhou Longshine Bio-Tech Co
- Anhui HaiKang: Confidential
Request Sample Report
Market Segmentation
By Application
Adults Patients
Elderly Patients
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
